Metabolites › ZPCCSZFPOXBNDL-RSMXASMKSA-N

spiramycin II

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy}-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl acetate

ZPCCSZFPOXBNDL-RSMXASMKSA-N CHEBI:31168 0 Reactome links 2 studies
2 Observed studies
2 Observed diff profiles
0 Reactome pathways

Metabolite details

Identifier
ZPCCSZFPOXBNDL-RSMXASMKSA-N
InChI Key
ZPCCSZFPOXBNDL-RSMXASMKSA-N
IUPAC name
(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-{[(2S,3R,4R,5S,6R)-5-{[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy}-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-10-{[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy}-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl acetate
Preferred name
spiramycin II
INN name
—
Synonym
Acetylspiramycin
ChEBI
CHEBI:31168

Reactome pathways

  • No Reactome pathways listed for this metabolite.

Observed in studies

Observed in differential profiles